1. Home
  2. LPSN vs OSRH Comparison

LPSN vs OSRH Comparison

Compare LPSN & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LivePerson Inc.

LPSN

LivePerson Inc.

HOLD

Current Price

$1.86

Market Cap

21.6M

Sector

Technology

ML Signal

HOLD

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.46

Market Cap

17.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPSN
OSRH
Founded
1995
N/A
Country
United States
United States
Employees
N/A
22
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
17.9M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
LPSN
OSRH
Price
$1.86
$0.46
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
64.2K
676.3K
Earning Date
05-06-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$249,838,000.00
N/A
Revenue This Year
N/A
$9.30
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$0.30
52 Week High
$7.54
$1.24

Technical Indicators

Market Signals
Indicator
LPSN
OSRH
Relative Strength Index (RSI) 51.63 58.12
Support Level $1.80 $0.40
Resistance Level $2.44 $0.45
Average True Range (ATR) 0.09 0.04
MACD 0.02 0.01
Stochastic Oscillator 90.22 67.93

Price Performance

Historical Comparison
LPSN
OSRH

About LPSN LivePerson Inc.

LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Companies enterprise-class digital customer conversation platform, is trusted by the brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United States, Asia-Pacific, Latin America, and Europe.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.

Share on Social Networks: